ResMed Inc.
As of Oct 22, 2026 close
- Market cap
- $36.69B
- P/E (TTM)
- 24.08
- Forward P/E
- 22.38
- Dividend yield
- 0.97%
- 52-week range
- $180.27$277.67
- Volume (live)
- -
- Avg. volume (3M)
- 1.15M
ResMed (RMD) Stock Price & Financial Analysis
ResMed Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $244.18 - $253.62 |
|---|---|
| 52-Week High | $277.67 |
| 52-Week Low | $180.27 |
| Open | $245.41 |
| Volume (last close) | 1.89M |
| Average Volume (3M) | 1.15M |
| Revenue (TTM) | 5.65B |
|---|---|
| Net Income (TTM) | 1.52B |
| Free Cash Flow (TTM) | 1.64B |
| EPS (TTM) | $10.40 |
| Profit Margin | 26.94% |
| Operating Margin | 33.76% |
| Return on Equity (ROE) | 23.13% |
| Debt to Equity | 0.13 |
| Annual Dividend | $2.46 |
|---|---|
| Dividend Yield | 0.97% |
| Payout Ratio | 23.66% |
| Last Dividend Ex-Date | Aug 20, 2026 |
| Market Cap | 36.69B |
|---|---|
| Shares Outstanding | 144.98M |
| P/E Ratio (TTM) | 24.08 |
| Forward P/E | 22.38 |
| Price to Sales (P/S) | 6.49 |
| Price to Book (P/B) | 5.57 |
| EV/EBITDA | 16.66 |
| 50-Day MA | $228.04 |
|---|---|
| 200-Day MA | $225.03 |
| 1-Year Change | −4.60% |
Source: Market prices and company fundamentals. Data as of Oct 22, 2026. Data sources and methodology
ResMed at a Glance
As of the Oct 22, 2026 close, ResMed (RMD) has a market capitalization of $36.69B. The stock trades at 24.1× trailing earnings, 22.4× forward earnings and 6.5× sales. Over the trailing twelve months it earned $1.52B on revenue of $5.65B (a 26.9% profit margin) and generated $1.64B of free cash flow. Revenue grew 9.8% year over year.
As of its latest reported balance sheet, it holds $1.47B in cash and securities against $825.92M of debt, a net cash position of $643.32M.
ResMed pays a quarterly dividend totaling $2.46 per share a year, a 0.97% yield at the Oct 22, 2026 close, with a 24% payout ratio and 13 consecutive years of dividend increases.
The share price is down 4.6% over the past year. At $253.06 (the Oct 22, 2026 close) it sits within its 52-week range of $180.26 to $277.67, above its 200-day moving average of $225.03.
Based on 14 professional analyst ratings from the past 90 days, the consensus is Hold with an average price target of $244.70, 3.3% below the Oct 22, 2026 close.
Frequently Asked Questions About ResMed
What is the current stock price for RMD?
As of the Oct 22, 2026 close, RMD stock trades at $253.06. The 52-week range is $180.27–$277.67, with a day range of $244.18–$253.62.
What is the P/E ratio for RMD?
As of the Oct 22, 2026 close, ResMed's trailing twelve-month (TTM) P/E ratio is 24.1, meaning investors pay $24.1 for every $1 of annual earnings. The forward P/E is 22.4, reflecting analyst expectations for future earnings. ResMed operates in the Healthcare sector.
Does RMD pay dividends?
Yes, ResMed pays a 0.97% annual dividend yield as of the Oct 22, 2026 close ($2.46 per share a year). The trailing twelve-month payout ratio is 23.7%. The most recent ex-dividend date was August 20, 2026.
What do analysts recommend for RMD?
Based on ratings from 14 professional analysts over the last 90 days, the consensus for RMD is Hold. The average 12-month price target is $244.70, a 3.3% downside from the Oct 22, 2026 close of $253.06.
What is the market cap of RMD?
As of the Oct 22, 2026 close, ResMed's market capitalization is $36.69B, classifying it as a large-cap company. ResMed operates in the Healthcare sector within the Medical Instruments & Supplies industry.